A detailed history of Old Port Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Old Port Advisors holds 27,034 shares of AZN stock, worth $1.82 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
27,034
Previous 27,480 1.62%
Holding current value
$1.82 Million
Previous $2.14 Billion 1.72%
% of portfolio
0.59%
Previous 0.64%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$76.67 - $87.62 $34,194 - $39,078
-446 Reduced 1.62%
27,034 $2.11 Billion
Q2 2024

Jul 18, 2024

SELL
$66.81 - $80.83 $27,926 - $33,786
-418 Reduced 1.5%
27,480 $2.14 Billion
Q1 2024

Jun 26, 2024

BUY
$61.03 - $69.57 $44,124 - $50,299
723 Added 2.66%
27,898 $1.89 Billion
Q4 2023

Jun 26, 2024

BUY
$61.89 - $69.28 $62,013 - $69,418
1,002 Added 3.83%
27,175 $1.83 Billion
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $15,693 - $17,351
242 Added 0.93%
26,173 $1.77 Billion
Q1 2023

Apr 12, 2023

BUY
$63.15 - $71.6 $56,014 - $63,509
887 Added 3.54%
25,931 $1.87 Billion
Q4 2022

Jan 11, 2023

BUY
$54.21 - $70.44 $50,523 - $65,650
932 Added 3.87%
25,044 $1.7 Billion
Q3 2022

Oct 13, 2022

BUY
$53.02 - $135.75 $32,448 - $83,079
612 Added 2.6%
24,112 $1.37 Million
Q2 2022

Jul 08, 2022

BUY
$59.26 - $71.14 $23,881 - $28,669
403 Added 1.74%
23,500 $1.54 Million
Q1 2022

Apr 12, 2022

BUY
$55.72 - $67.12 $32,986 - $39,735
592 Added 2.63%
23,097 $1.54 Million
Q4 2021

Jan 12, 2022

BUY
$54.02 - $63.83 $45,268 - $53,489
838 Added 3.87%
22,505 $1.28 Million
Q3 2021

Oct 12, 2021

BUY
$55.56 - $60.79 $293,634 - $321,275
5,285 Added 32.26%
21,667 $1.3 Million
Q2 2021

Jul 20, 2021

BUY
$48.42 - $60.18 $513,929 - $638,750
10,614 Added 184.02%
16,382 $980,000
Q1 2021

Apr 08, 2021

BUY
$47.16 - $54.44 $272,018 - $314,009
5,768 New
5,768 $287,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Old Port Advisors Portfolio

Follow Old Port Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Port Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Old Port Advisors with notifications on news.